3-D Biomimetic Scaffolds for Bone Tissue Engineering

描述（由申请人提供）：口面骨骼缺损的重建是一项重大的临床挑战，每年进行超过100万例外科手术。由于现有技术的局限性，需要新的骨再生策略。我们和其他人已经证明，从人类和动物骨髓抽吸物中扩增的细胞以及从骨碎片中收获的成骨细胞能够在体内形成新骨。然而，分化的速率和程度以及新骨形成的程度是不可预测的，并且取决于细胞微环境中的因素，其中显然包括支持生物材料。在该资助的第一个周期中，我们开发了基于生物矿物质在有机模板上的3D自组装的仿生材料。我们证明，在体外（细胞粘附，增殖，细胞骨架组织，成骨分化）和体内功能（再生骨的体积分数）的骨祖细胞是可重复地增强，与聚合物对照相比，通过控制成核和生长的一层骨样矿物质的有机模板。通过改变矿物组成，我们能够合成一系列的矿物表面，表现出可控的溶解度，和初步的数据表明，溶解产物的仿生层（即钙离子）增强细胞功能本身，独立于直接底物介导的影响。总的来说，这些数据证明了可控地自组装纳米级矿物类似物的能力，提供基于材料的控制细胞功能，并且细胞对生物材料扰动的响应是表面和溶液介导的（无机可溶性因子）途径的叠加。总之，这些结果形成了在这种竞争性更新中待测试的全局假设的基础：由生物材料提供的细胞外微环境控制祖细胞通过溶液以及基质介导的效应增殖和分化成骨细胞表型的能力，这些效应共同可以指导细胞再生矿化基质。进一步假设，可溶性较低的物质（表面介导的作用）促进祖细胞增殖，而可溶性较高的物质（溶液介导的作用）促进细胞分化。通过合成一系列仿生材料来测试这些假设，所述仿生材料包括具有表面的聚合物支架，所述表面根据热力学条件自矿化成受控组成和溶解度的生物磷灰石，并评估人祖细胞对这些仿生变体的体外和体内反应。这些研究的结果可能会导致生物材料的发展，更好地控制骨形成的祖细胞。如果细胞对生物材料的反应是表面和可溶性因子介导的途径的叠加，这可能代表了理解细胞/生物材料相互作用的新范式，并且还导致基于直接呈现可溶性无机因子的治疗策略的发展，以微创的方法进行组织工程。 口面部骨骼缺损的重建是一项重大的临床挑战，每年进行超过100万例外科手术。由于现有技术的局限性，需要新的骨再生策略。从人骨髓抽吸物扩增的细胞能够在体内形成新骨。然而，新骨形成的程度是不可预测的，并且取决于细胞微环境中的因素，包括支持生物材料。在这个提议中，我们将证明生物材料可以通过材料的表面特性和从材料释放的可溶性离子种类来控制细胞功能和骨再生。这些研究的结果可能会导致生物材料的发展，更好地控制骨形成的祖细胞。如果细胞对生物材料的反应是表面和可溶性因子介导的途径的叠加，这可能代表了理解细胞/生物材料相互作用的新范式，并且还导致基于直接呈现可溶性无机因子的治疗策略的发展，以微创的方法进行组织工程。此外，表面和可溶性因子效应之间的平衡也可以解释纳米结构材料优越的上级生物性能。

DESCRIPTION (provided by applicant): Reconstruction of orofacial skeletal defects represents a major clinical challenge, with over 1 million surgical procedures performed each year. New strategies of regenerating bone are needed because of limitations with existing techniques. We and others have shown that cells expanded from human and animal bone marrow aspirates, as well as osteoblasts harvested from bone fragments, are capable of forming new bone in-vivo. However, the rate and extent of differentiation and degree of new bone formation are unpredictable, and dependent upon factors in the cellular microenvironment, which clearly include the supporting biomaterial. In the first cycle of this grant, we developed biomimetic materials based on the 3D self-assembly of biological minerals onto organic templates. We demonstrated that the in-vitro (cell adhesion, proliferation, cytoskeletal organization, osteogenic differentiation) and in-vivo function (volume fraction of regenerated bone) of osteoprogenitor cells was reproducibly enhanced, compared to polymer controls, by controlling the nucleation and growth of a layer of bone-like mineral onto an organic template. By altering mineral composition, we were able to synthesize a series of mineral surfaces which exhibited controllable solubility, and preliminary data suggests that the dissolution products of the biomimetic layer (i.e. Ca ions) enhance cell function by themselves, independent of direct substrate-mediated effects. Collectively, these data demonstrate the ability to controllably self-assemble nanoscale mineral analogues, providing material-based control over cell function, and that the response of cells to biomaterial perturbations is the superposition of surface and solution-mediated (inorganic soluble factor) pathways. Taken together, these results form the basis for the global hypothesis to be tested in this competing renewal: the extracellular microenvironment provided by a biomaterial controls the ability of progenitor cells to proliferate and differentiate toward an osteoblast phenotype through solution as well as substrate-mediated effects, which collectively can direct cells to regenerate a mineralized matrix. It is further hypothesized that less soluble materials (surface-mediated effects) promote progenitor cell proliferation, whereas more soluble materials (solution-mediated effects) promote cell differentiation. These hypotheses are tested by synthesizing a series of biomimetic materials that includes polymer scaffolds with surfaces that self-mineralize into a biological apatite of controlled composition and solubility, depending on thermodynamic conditions, and assessing the in-vitro and in-vivo response of human progenitor cells to these biomimetic variants. The results of these studies could lead to the development of biomaterials that better control bone formation by progenitor cells. If the response of cells to a biomaterial is the superposition of surface and soluble factor-mediated pathways, this could represent a new paradigm in understanding cell/biomaterial interactions, and also lead to the development of therapeutic strategies based on a direct presentation of soluble inorganic factors, in a less invasive approach to tissue engineering. PUBLIC HEALTH RELEVANCE Reconstruction of orofacial skeletal defects represents a major clinical challenge, with over 1 million surgical procedures performed each year. New strategies of regenerating bone are needed because of limitations with existing techniques. Cells expanded from human bone marrow aspirates are capable of forming new bone in-vivo. However, the degree of new bone formation is unpredictable, and dependent upon factors in the cellular microenvironment, including the supporting biomaterial. In this proposal, we will demonstrate that a biomaterial can control cell function and bone regeneration by both its surface properties of the material and soluble ionic species released from the material. Results of these studies could lead to the development of biomaterials that better control bone formation by progenitor cells. If the response of cells to a biomaterial is the superposition of surface and soluble factor-mediated pathways, this could represent a new paradigm in understanding cell/ biomaterial interactions, and also lead to the development of therapeutic strategies based on a direct presentation of soluble inorganic factors, in a less invasive approach to tissue engineering. Moreover, the balance between surface and soluble factor effects could also explain the superior biological performance of nanostructured materials.